Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$4.39B
Total Bought:
$4.01B
Total Sold:
$11.04M
Net Transaction:
+$4.00B
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Kenvue Inc.(KVUE)0182,329,550+182,329,550$0$3.93B89.50%+$3.93B
CVRx, Inc.(CVRX)3,495,5753,495,5750$53.03M$109.90M2.51%+$56.87M
Protagonist Therapeutics Inc.2,449,1832,449,1830$40.85M$56.16M1.28%+$15.31M
Legend Biotech CorporationADS(LEGN)814,586814,5860$54.72M$49.01M1.12%-$5.70M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$32.61M$46.62M1.06%+$14.01M
Nanobiotix S.A.ADS(NBTX)959,6375,623,816+4,664,179$8.40M$40.94M0.93%+$32.54M
Fusion Pharmaceuticals Inc.3,670,5163,670,5160$9.54M$35.27M0.80%+$25.73M
Shockwave Medical, Inc.0166,812+166,812$0$31.79M0.72%+$31.79M
Neumora Therapeutics, Inc.(NMRA)912,1281,849,445+937,317$12.87M$31.53M0.72%+$18.66M
Xencor, Inc.(XNCR)748,062748,0620$15.07M$15.88M0.36%+$807.9K
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$11.74M$15.00M0.34%+$3.26M
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$7.16M$12.64M0.29%+$5.47M
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$6.65M$7.58M0.17%+$923.5K
Vor Biopharma Inc.(VOR)1,074,6581,074,6580$2.28M$2.42M0.06%+$139.7K
Nano-X Imaging Ltd.
ORD SHS
317,704317,7040$2.08M$2.02M0.05%-$60.4K
Adicet Bio, Inc.728,944688,595-40,349$998.7K$1.30M0.03%+$302.8K
Aldeyra Therapeutics, Inc.(ALDX)394,834299,669-95,165$2.64M$1.05M0.02%-$1.59M
SomaLogic, Inc.281,052281,0520$671.7K$711.1K0.02%+$39.3K
Tessera Defense and Homeland Security Inc.(HLSQ)2,133,4022,133,4020$751.0K$597.4K0.01%-$153.6K
Clearside Biomedical, Inc.169,629169,6290$147.6K$198.5K0.00%+$50.9K
Senseonics Holdings, Inc.(SENS)54,62154,6210$33.0K$31.1K0.00%-$1.8K
Tracon Pharmaceuticals, Inc.84,00384,0030$15.0K$14.7K0.00%-$244
Apollomics, Inc.CL A(APLM)13,25213,2520$49.6K$12.8K0.00%-$36.8K
Catalyst Biosciences, Inc.COM66,9510-66,951$32.3K$0—-$32.3K
Cue Health, Inc.COM5,548,8640-5,548,864$2.45M$0—-$2.45M
Point Biopharma Global Inc.COM1,000,0000-1,000,000$6.67M$0—-$6.67M
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q4 2023 | TickerTrail